Banka BioLoo Latest Share Price (BANKA)
TODAY IN ONE LINE
BANKA surged 5.0% on above-average volume (1373958.3x avg), outperforming Nifty's -0.1% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹89.06 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Banka BioLoo flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 52.1% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Price MomentumStock underperformed, dropping 14.9% over 1Y
- ●Sales ContractionQuarterly sales dropped 13.6% YoY
- ●Poor Capital ReturnsLow ROE of 0.9%
- ●Promoter SellingPromoter holding decreased by 0.15% QoQ
- ●Rising Receivables vs SalesReceivables grew 22.6% outpacing sales growth of 8.4%
Latest Banka BioLoo News
What changed recently?
Recent events, corporate actions, and announcements.
Banka BioLoo Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Banka BioLoo Limited, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Banka BioLoo Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Banka BioLoo Limited — derived from the latest tape, not yesterday's close.
Banka BioLoo Limited last traded at ₹81.9 with an intraday range of ₹77.21–₹81.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹81.90| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 92.84 | +10.94 | +13.36% |
| R3 | 88.15 | +6.25 | +7.64% |
| R2 | 85.03 | +3.13 | +3.82% |
| R1 | 83.46 | +1.56 | +1.91% |
| PIVOT | 80.34 | -1.56 | -1.91% |
| CURRENT | 81.90 | — | — |
| S1 | 78.77 | -3.13 | -3.82% |
| S2 | 75.65 | -6.25 | -7.64% |
| S3 | 74.08 | -7.82 | -9.54% |
| S4 | 69.39 | -12.51 | -15.27% |
BANKA is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹77.21–₹78.01
Trading Above opening range, showing Bullishness
Banka BioLoo Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Banka BioLoo Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Banka BioLoo Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹89.06 Cr. and reported EPS of ₹0.32.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 54 | 57 ▲ 5.4% |
| Sales Growth YoY %Derived | 8.36% | 5.39% |
| Other Income | 0 | 1 ▲ 294.7% |
| Total Income | 55 | 58 ▲ 7.1% |
| 16 | 14 ▼ 12.1% | |
| Gross ProfitDerived | 38 | 43 ▲ 12.7% |
| Gross Margin %Derived | 70.54% | 75.44% |
| 41 | 38 ▼ 7.8% | |
| EBITDA (Operating Profit)Derived | -3 | 5 ▲ 280.9% |
| OPM %Derived | -5.30% | 9.10% |
| 6 | 6 ▲ 3.6% | |
| Profit Before Tax (PBT) | -9 | -0 ▲ 96.8% |
| -0 | -1 ▼ 205.9% | |
| Effective Tax %Derived | 2.35% | 223.78% |
| Total Profit for Period | -9 | 0 ▲ 104.4% |
| Less: Non-controlling Interests | — | 0 |
| Net Profit (Owner's PAT)Derived | -9 | 0 ▲ 103.9% |
| Net Profit Margin %Derived | -16.44% | 0.62% |
| PAT Growth YoY %Derived | -1,265.30% | 103.94% |
| Earnings Per Share (EPS ₹) | -8.19 | 0.32 ▲ 103.9% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.4% |
| Share of Profit from Associates/JVs | 0 | 0 ▲ 3.2% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 7.6% |
| Total Expenses (incl. D&A & Interest) | 64 | 59 ▼ 7.8% |
| Material Cost % of RevenueDerived | 28.67% | 24.12% |
| Employee Cost % of RevenueDerived | 53.80% | 48.72% |
| Other Cost % of RevenueDerived | 22.04% | 17.62% |
| Interest Coverage (x)Derived | -1.44x | 0.65x |
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 30 | 39 ▲ 27.2% | 42 ▲ 9.3% | 50 ▲ 18.1% | 54 ▲ 8.4% | 57 ▲ 5.4% | |
| Sales Growth YoY %Derived | — | 27.23% | 9.29% | 18.06% | 8.36% | 5.39% | |
| Other Income | 1 | 0 ▼ 21.3% | 1 ▲ 54.5% | 0 ▼ 29.5% | 0 ▼ 33.7% | 1 ▲ 294.7% | |
| Total Income | 31 | 39 ▲ 26.3% | 43 ▲ 9.8% | 50 ▲ 17.3% | 55 ▲ 7.9% | 58 ▲ 7.1% | |
4 | 7 ▲ 76.4% | 6 ▼ 17.6% | 16 ▲ 193.2% | 16 ▼ 1.7% | 14 ▼ 12.1% | ||
| Gross ProfitDerived | 27 | 32 ▲ 20.2% | 37 ▲ 14.9% | 34 ▼ 8.3% | 38 ▲ 13.2% | 43 ▲ 12.7% | |
| Gross Margin %Derived | 87.49% | 82.66% | 86.92% | 67.52% | 70.54% | 75.44% | |
23 | 27 ▲ 14.1% | 31 ▲ 16.4% | 30 ▼ 2.4% | 41 ▲ 36.4% | 38 ▼ 7.8% | ||
| EBITDA (Operating Profit)Derived | 3 | 6 ▲ 61.7% | 6 ▲ 8.0% | 4 ▼ 39.0% | -3 ▼ 179.2% | 5 ▲ 280.9% | |
| OPM %Derived | 11.18% | 14.21% | 14.04% | 7.25% | -5.30% | 9.10% | |
2 | 3 ▲ 26.9% | 3 ▲ 13.1% | 5 ▲ 53.9% | 6 ▲ 28.2% | 6 ▲ 3.6% | ||
| Profit Before Tax (PBT) | 2 | 3 ▲ 75.5% | 4 ▲ 10.2% | -1 ▼ 115.0% | -9 ▼ 1587.6% | -0 ▲ 96.8% | |
-0 | 0 ▲ 159.8% | 1 ▲ 439.0% | 0 ▼ 90.1% | -0 ▼ 299.5% | -1 ▼ 205.9% | ||
| Effective Tax %Derived | -17.99% | 6.13% | 29.99% | -19.88% | 2.35% | 223.78% | |
| Total Profit for Period | 2 | 3 ▲ 40.9% | 3 ▼ 18.3% | -1 ▼ 126.4% | -9 ▼ 1227.5% | 0 ▲ 104.4% | |
| Less: Non-controlling Interests | — | — | — | -0 | — ▲ 100.0% | 0 | |
| Net Profit (Owner's PAT)Derived | 2 | 3 ▲ 40.9% | 3 ▼ 18.3% | -1 ▼ 125.7% | -9 ▼ 1265.3% | 0 ▲ 103.9% | |
| Net Profit Margin %Derived | 7.24% | 8.02% | 6.00% | -1.31% | -16.44% | 0.62% | |
| PAT Growth YoY %Derived | — | 40.94% | -18.30% | -125.70% | -1,265.30% | 103.94% | |
| Earnings Per Share (EPS ₹) | 2.14 | 3.02 ▲ 41.1% | 2.34 ▼ 22.5% | -0.46 ▼ 119.7% | -8.19 ▼ 1680.4% | 0.32 ▲ 103.9% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 5.5% | 1 ▲ 0.0% | 1 ▲ 0.3% | 1 ▲ 0.4% | |
| Share of Profit from Associates/JVs | -0 | 0 ▲ 1694.1% | 0 ▼ 76.4% | -0 ▼ 428.1% | 0 ▲ 235.2% | 0 ▲ 3.2% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▼ 83.4% | 0 ▲ 70.9% | 0 ▲ 168.5% | 0 ▲ 14.5% | 0 ▼ 7.6% | |
| Total Expenses (incl. D&A & Interest) | 29 | 36 ▲ 23.2% | 39 ▲ 9.8% | 51 ▲ 29.4% | 64 ▲ 24.7% | 59 ▼ 7.8% | |
| Material Cost % of RevenueDerived | 23.06% | 20.09% | 14.01% | 21.55% | 28.67% | 24.12% | |
| Employee Cost % of RevenueDerived | 42.76% | 45.84% | 55.96% | 47.87% | 53.80% | 48.72% | |
| Other Cost % of RevenueDerived | 33.54% | 22.60% | 16.91% | 12.40% | 22.04% | 17.62% | |
| Interest Coverage (x)Derived | 1.85x | 2.63x | 2.88x | 0.58x | -1.44x | 0.65x |
Banka BioLoo segment analysis : revenue and profit mix.
Disclosed business segments at Banka BioLoo with their share of revenue and profit, switchable between consolidated and standalone reporting.
Banka BioLoo discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Banka BioLoo Limited.
Our AI distills the core fundamental drivers supporting Banka BioLoo Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Banka BioLoo Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Majority promoter holding of 52.07% signals strong insider confidence and long-term commitment.
Proprietary BioToilet, BioDigester, FootLoo systems offer competitive differentiation in sanitation sector.
Established track record with Indian Railways demonstrates large-scale project execution capability.
Operating margin of 5.95% TTM shows ability to generate positive operational returns despite headwinds.
Small market cap of ₹89.53 Cr provides significant scaling potential for future growth operations.
Key Risks.
Latest quarterly EPS declined 96.60% YoY, demonstrating severe earnings deterioration and value destruction.
TTM EPS of -3.83 ₹/share reflects persistent losses and poor shareholder value creation.
Latest quarterly sales declined 13.60% YoY, signaling weakening market demand and project pipeline weakness.
ROE of 0.92% and ROCE of -7.61% indicate severe operational inefficiencies and capital misallocation.
Negative operating cash flow in FY2025 (₹0.71 Cr) and FY2022 strains financial flexibility and growth investments.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.42. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Banka BioLoo Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Banka BioLoo Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Banka BioLoo Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Banka BioLoo Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Banka BioLoo Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Banka BioLoo Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Banka BioLoo Limited stood at 60.6% of traded volume, against a 20-day average of 79.9%.
Banka BioLoo announcements: results, concalls, ratings, M&A.
Filings Banka BioLoo sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Banka BioLoo files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 68 documents below.
Copy of Newspaper Publication
Banka BioLoo Limited has informed the Exchange about the copy of the newspaper publication.
Copy of Newspaper Publication
Banka BioLoo Limited has informed the Exchange about Copy of Newspaper Publication
Investor Presentation
Banka BioLoo Limited has informed the Exchange about Investor Presentation
Integrated Filing- Financial
Board meeting- Integrated Financial filings
Outcome of Board Meeting
Banka BioLoo Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026.
Investor decks & rating reports.
Banka BioLoo dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Banka BioLoo has declared, sequenced by announce and record date.
Banka BioLoo corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Banka BioLoo Limited: business, sector, key facts.
What Banka BioLoo Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Banka BioLoo Limited operates in the Civil Construction industry under the Construction sector, listed as NSE: BANKA.
Banka BioLoo Limited is an Indian sanitation and wastewater treatment company established in 2012 and headquartered in Hyderabad. Their core business revolves around the design, installation, operation, and maintenance of various wastewater and fecal sludge treatment systems. This includes a wide range of solutions tailored for diverse clients and applications.
A significant part of Banka BioLoo's operations focuses on the development and deployment of its proprietary sanitation technologies. These include the BioToilet, BioDigester, and FootLoo systems, which are designed to address sanitation challenges efficiently and sustainably. The company also offers packaged and urban sewage treatment plants, catering to a broader range of needs, from individual households to large-scale municipal projects.
Beyond individual and community-based solutions, Banka BioLoo extends its services to industrial and commercial sectors. Their expertise is leveraged by various businesses to manage their wastewater effectively and comply with environmental regulations. A notable example of their large-scale projects is their involvement in the installation and maintenance of bio-toilets for Indian Railways, showcasing their capacity to handle substantial contracts.
The company’s commitment to sustainability is further highlighted by its production of granules and biopellets for compostable packaging. This demonstrates a broader engagement in waste management and the circular economy, reducing reliance on non-biodegradable materials. In essence, Banka BioLoo offers a comprehensive suite of services covering the entire spectrum of sanitation and wastewater treatment, contributing significantly to improved hygiene and environmental protection in India.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- A B Infrabuild (ABINFRA) Share PricePeer
- Afcons Infrastructure (AFCONS) Share PricePeer
- Akash Infra-Projects (AKASH) Share PricePeer
- BCPL Railway Infrastructure (BCPL) Share PricePeer
- Central Mine Planning & Design Institute (CMPDI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Banka BioLoo Limited (BANKA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Banka BioLoo Limited (BANKA)?
The current share price of Banka BioLoo Limited (BANKA) is ₹81.90. Today, the stock has gained by ₹3.90 (5%), trading in a range of ₹77.21 to ₹81.90. The stock opened at ₹77.61 with a trading volume of 6,595 shares.
02What is the 52-week high and low price of Banka BioLoo Limited stock?
The 52-week high price of Banka BioLoo Limited (BANKA) is ₹97.88, while the 52-week low is ₹41.00. Currently trading at ₹81.90, the stock is 99.76% above its 52-week low and 16.33% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of Banka BioLoo Limited and when is the next dividend?
Banka BioLoo Limited offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹81.90, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is Banka BioLoo Limited stock performing today in the market?
Banka BioLoo Limited stock opened at ₹77.61 and is currently trading at ₹81.90, showing a gain of ₹3.90 (5%). The intraday high is ₹81.90 and low is ₹77.21. The trading volume stands at 6,595 shares, indicating moderate market participation today.
05What is the market capitalization of Banka BioLoo Limited?
Banka BioLoo Limited has a market capitalization of ₹89.06 Cr., making it a large-cap company. Market cap is calculated by multiplying the current stock price (₹81.90) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of Banka BioLoo Limited?
Banka BioLoo Limited has a Return on Equity (ROE) of 0.92% and Return on Capital Employed (ROCE) of -7.61%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does Banka BioLoo Limited belong to?
Banka BioLoo Limited operates in the Construction sector and belongs to the Civil Construction industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the debt-to-equity ratio of Banka BioLoo Limited?
Banka BioLoo Limited has a debt-to-equity ratio of 0.92, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
The data, ratios and commentary about Banka BioLoo Limited (BANKA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.